Amarantus BioSciences Explores Orphan Drug Strategy Based on MANF Protein

Amarantus BioSciences Explores Orphan Drug Strategy Based on MANF Protein

Filed under: drug treatment news

The Orphan Drug Act (ODA) provides for granting special status to a product to treat a rare disease or condition upon request of a sponsor. The combination of the product to treat the rare disease or condition must meet certain criteria. This status is …
Read more on Sacramento Bee

 

Creatinine cutoffs for treatment guidance questioned in HTN with CKD

Filed under: drug treatment news

Chicago, IL – The "30% rule" for guiding antihypertensive drug therapy in patients with chronic kidney disease (CKD), which refers to the serum creatinine increase that should trigger dosage cutbacks, may be unnecessary in the contemporary era of …
Read more on TheHeart.Org

 

Smart Polymers Allow More Subtle Control and Timing of Drug Delivery

Filed under: drug treatment news

Better control over the delivery of drugs to specific sites in the body at specific times would reduce unwanted side effects and improve medical treatment dramatically. 'Smart' polymers are promising materials for controlling drug delivery, since they …
Read more on Azom.com